From: Mining metastasis related genes by primary-secondary tumor comparisons from large-scale databases
Class | Gene | B vs. C | Liver viability | Difference | Liver and metastasis dependency |
---|---|---|---|---|---|
B↔C only | COLEC11 | 3.95 | 2.45 | 1.49 | Liver up-regulated |
NRBP2 | 3.29 | 3.57 | -0.28 | Liver up-regulated | |
FGG | 3.26 | 3.81 | -0.55 | Liver specific | |
ART4 | 3.19 | 2.08 | 1.10 | Liver specific | |
LBP | 3.15 | 3.44 | -0.28 | - | |
GADD45B | 3.15 | 2.82 | 0.33 | - | |
HP /// HPR | 3.11 | 3.69 | -0.58 | Liver specific | |
ALB | 3.088 | 3.80 | -0.71 | Liver specific | |
C10ORF11 | 3.06 | 2.25 | 0.80 | - | |
GCKR | 3.03 | 3.40 | -0.36 | - | |
Modified with liver viability | MGC16121 | 2.43 | -1.39 | 3.83 | Unknown |
HS3ST2 | 2.34 | -0.39 | 2.74 | - | |
DHRS12 | 2.11 | -0.43 | 2.54 | - | |
MSR1 | 2.07 | -0.33 | 2.41 | Inflammation | |
DNASE1 | 2.10 | -0.23 | 2.33 | - | |
MARCO | 2.86 | 0.55 | 2.31 | Macrophage receptor | |
SPAG4 | 2.18 | -0.10 | 2.28 | - | |
INMT | 2.93 | 0.71 | 2.22 | - | |
AOAH | 2.45 | 0.26 | 2.19 | Metastasis related | |
EPO | 2.20 | 0.14 | 2.05 | Cancer and metastasis |